IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q1 2024 Holdings

Filed 2024-05-15 | 11 holdings | $17.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Xeris Biopharma Holdings Inc(XERS)COM98422E103$11.3M5,113,34864.4%
Rezolute Inc(RZLT)COM NEW76200L309$3.4M1,318,96719.2%
Spdr S&P 500 ETF TR(SPY)TR UNIT78462F103$971.0K1,8565.5%
Berkshire Hathaway Inc del(BRK/B)CL B NEW084670702$428.3K1,0192.4%
Kyverna Therapeutics Inc(KYTX)COM501976104$393.6K15,8462.2%
Molecular Templates IncCOM NEW608550208$306.6K136,8661.7%
Mind Medicine Mindmed Inc(BRD1EUR)COM NEW60255C885$273.2K29,0651.6%
Abivax SA(ABVX)SPONSORED ADS00370M103$226.1K15,8081.3%
Lexeo Therapeutics Inc(LXEO)COM52886X107$161.8K10,3190.9%
Compass Therapeutics Inc(CMPX)COM20454B104$86.1K43,4650.5%
Adicet BIO Inc(TORCEUR)COM007002108$41.1K17,4880.2%